Demonstrating preclinical efficacy of AUY922, a novel Hsp90 inhibitor, alone and in combination with standard chemotherapy or radiation in esophageal adenocarcinoma.
Juliann Kosovec
No relevant relationships to disclose
Christina Rotoloni
No relevant relationships to disclose
Ali H Zaidi
No relevant relationships to disclose
Yoshihiro Komastu
No relevant relationships to disclose
Lori Kelly
No relevant relationships to disclose
Daisuke Matsui
No relevant relationships to disclose
Amina Waheed
No relevant relationships to disclose
Toshitaka Hoppo
No relevant relationships to disclose
Blair A Jobe
No relevant relationships to disclose